[Form 4] Babcock & Wilcox Enterprises, Inc. 8.125% Senior Notes due 2026 Insider Trading Activity

Rhea-AI Filing Summary

Cameron M. Frymyer, Chief Financial Officer of Babcock & Wilcox Enterprises, Inc. (BWSN), reported an insider purchase of common stock. The Form 4 shows a purchase on 08/19/2025 of 20,000 shares at a price of $1.55 per share, increasing his beneficial ownership to 153,805 shares. The filing was signed by an attorney-in-fact on 08/20/2025. No derivative transactions were reported and no other material details are provided.

Positive

• CFO purchased shares, signaling insider buying at $1.55 per share
• Beneficial ownership increased to 153,805 shares after the transaction
• Form 4 disclosure appears complete with transaction date and signature

Negative

• None.

Insights

Securities Analyst

TL;DR: CFO purchased 20,000 BWSN shares at $1.55, modestly increasing insider stake to 153,805 shares.

The transaction is a straightforward open-market purchase by the company's CFO, reported on Form 4. At 20,000 shares and $1.55 per share, the trade size appears modest relative to typical institutional thresholds; it does, however, indicate management-level buying interest. The filing contains no derivatives, no plan designation (10b5-1), and no additional context such as large block trades or related-party involvement. Impact on valuation is limited given the small size, so this is a routine insider purchase from a disclosure perspective.

Corporate Governance Expert

TL;DR: Insider disclosure is complete for the reported transaction and shows a direct beneficial increase.

The Form 4 properly discloses the reporting person, relationship (CFO), transaction date, price, and resulting beneficial ownership. The signature is provided by an attorney-in-fact, dated 08/20/2025, which satisfies execution formalities. There are no indications of planned trading arrangements or derivative activity in this filing. Governance-wise, the disclosure aligns with Section 16 requirements and raises no procedural concerns.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Frymyer Cameron M

(Last) (First) (Middle)

1200 E. MARKET STREET, SUITE 650

(Street)

AKRON OH 44305

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Babcock & Wilcox Enterprises, Inc. [ BW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/19/2025		P		20,000	A	$1.55	153,805	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ John J. Dziewisz, Attorney-in-Fact for Cameron M. Frymyer	08/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did BWSN insider Cameron Frymyer report on Form 4?

He reported a purchase of 20,000 common shares on 08/19/2025 at $1.55 per share, raising his beneficial ownership to 153,805 shares.

When was the Form 4 for Cameron Frymyer signed?

The filing was signed by an attorney-in-fact on 08/20/2025 as shown on the Form 4.

Did the Form 4 report any derivative transactions for BWSN?

No derivatives were reported in Table II; only a non-derivative purchase of common stock is listed.

Was the purchase executed under a 10b5-1 plan according to this Form 4?

The Form 4 does not indicate the transaction was made pursuant to a 10b5-1 plan; no plan designation is provided.

How much did the insider pay in total for the reported shares?

Total consideration reported is $31,000 (20,000 shares at $1.55 per share).